Company profile for Gain Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Gain Therapeutics is redefining drug discovery with its SEE-Tx™ target identification platform. By identifying and optimizing allosteric binding sites that have never before been targeted, Gain is unlocking new treatment options for difficult-to-treat disorders characterized by protein misfolding, including lysosomal storage disorders. Protein misfolding is an underlying biological issue of many diseases, including lysos...
Gain Therapeutics is redefining drug discovery with its SEE-Tx™ target identification platform. By identifying and optimizing allosteric binding sites that have never before been targeted, Gain is unlocking new treatment options for difficult-to-treat disorders characterized by protein misfolding, including lysosomal storage disorders. Protein misfolding is an underlying biological issue of many diseases, including lysosomal storage disorders and some neurodegenerative diseases such as Parkinson’s disease. When a protein misfolds, its 3D structure is disrupted and it can no longer function properly.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
4800 Hampden Ln, St 200 Bethesda, MD 20814
Telephone
Telephone
+1 301 500 1556
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/20/3191774/0/en/Gain-Therapeutics-Presents-Preclinical-GT-02287-Data-at-Neuroscience-2025.html

GLOBENEWSWIRE
20 Nov 2025

https://www.globenewswire.com/news-release/2025/11/12/3186081/0/en/Gain-Therapeutics-Reports-Financial-Results-for-Third-Quarter-2025-and-Provides-Corporate-Update.html

GLOBENEWSWIRE
12 Nov 2025

https://www.globenewswire.com/news-release/2025/10/30/3177226/0/en/Gain-Therapeutics-to-Present-at-Neuroscience-2025.html

GLOBENEWSWIRE
30 Oct 2025

https://www.globenewswire.com/news-release/2025/10/16/3167767/0/en/Gain-Therapeutics-to-Attend-the-2025-Maxim-Growth-Summit.html

GLOBENEWSWIRE
16 Oct 2025

https://www.globenewswire.com/news-release/2025/10/09/3163998/0/en/Gain-Therapeutics-to-Host-Virtual-KOL-Event-on-GT-02287-for-Parkinson-s-Disease.html

GLOBENEWSWIRE
09 Oct 2025

https://www.globenewswire.com/news-release/2025/10/06/3161695/0/en/Gain-Therapeutics-Presents-Initial-Data-from-Phase-1b-Clinical-Study-of-GT-02287-in-Parkinson-s-Patients-at-International-Congress-of-Parkinson-s-Disease-and-Movement-Disorders.html

GLOBENEWSWIRE
06 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty